-
EP1434779
European procedure
Extract from the Register of European Patents
EP About this file: EP1434779
| EP1434779 - CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.11.2006 Database last updated on 10.07.2024 | Most recent event Tooltip | 09.11.2007 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 12.12.2007 [2007/50] | Applicant(s) | For all designated states Theravance, Inc. 901 Gateway Boulevard South San Francisco, CA 94080 / US | [2004/28] | Inventor(s) | 01 /
FATHEREE, Paul 921 Minnesota Street San Francisco, CA 94107 / US | 02 /
LINSELL, Martin, S. 602 East 16th Avenue San Mateo, CA 94402 / US | 03 /
LONG, Daniel, D. 3855 21st Street 3 San Francisco, CA 94114 / US | 04 /
MARQUESS, Daniel 2037 Touraine Lane Half Moon Bay, CA 94019 / US | 05 /
MORAN, Edmund, J. 131 Chaves San Francisco, CA 94127 / US | 06 /
NODWELL, Matthew, B. #8, 1346 Cotton Drive Vancouver, British Columbia V5L 3T7 / CA | 07 /
TURNER, S., Derek 804 Fell Street San Francisco, CA 94117 / US | 08 /
AGGEN, James 1311 California Drive Burlingame, CA 94010 / US | [2004/28] | Representative(s) | Hay, Martin Alexander, et al Martin A. Hay & Co. White Cottage 33 Castle Hill Prestbury Cheshire SK10 4AS / GB | [N/P] |
| Former [2004/28] | Hay, Martin Alexander, et al Martin A. Hay & Co. 13 Queen Victoria Street Macclesfield Cheshire SK11 6LP / GB | Application number, filing date | 02769054.4 | 11.10.2002 | [2004/28] | WO2002US32534 | Priority number, date | US20010328889P | 12.10.2001 Original published format: US 328889 P | [2004/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03031449 | Date: | 17.04.2003 | Language: | EN | [2003/16] | Type: | A2 Application without search report | No.: | EP1434779 | Date: | 07.07.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.04.2003 takes the place of the publication of the European patent application. | [2004/28] | Type: | B1 Patent specification | No.: | EP1434779 | Date: | 28.12.2005 | Language: | EN | [2005/52] | Search report(s) | International search report - published on: | EP | 28.08.2003 | Classification | IPC: | C07D501/00, C07K9/00, C07D501/20, A61K31/545, A61K38/04, A61P31/00 | [2004/28] | CPC data not yet available | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/28] | Extension states | AL | 21.04.2004 | LT | 21.04.2004 | LV | 21.04.2004 | MK | 21.04.2004 | RO | 21.04.2004 | SI | 21.04.2004 | Title | German: | KREUZVERQUERTE GLYCOPEPTID-CEPHALOSPORIN-ANTIBIOTIKA | [2004/28] | English: | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS | [2004/28] | French: | ANTIBIOTIQUES RETICULES GLYCOPEPTIDE-CEPHALOSPORINE | [2004/28] | Entry into regional phase | 05.04.2004 | National basic fee paid | 05.04.2004 | Designation fee(s) paid | 05.04.2004 | Examination fee paid | Examination procedure | 10.03.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 05.04.2004 | Amendment by applicant (claims and/or description) | 05.04.2004 | Examination requested [2004/28] | 28.12.2004 | Despatch of a communication from the examining division (Time limit: M02) | 15.01.2005 | Reply to a communication from the examining division | 11.03.2005 | Communication of intention to grant the patent | 25.08.2005 | Fee for grant paid | 25.08.2005 | Fee for publishing/printing paid | Opposition(s) | 29.09.2006 | No opposition filed within time limit [2006/49] | Fees paid | Renewal fee | 25.10.2004 | Renewal fee patent year 03 | 27.10.2005 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2007/50] |
| Former [2007/39] | IT | 28.12.2005 | Cited in | International search | [DA]US5693791 (TRUETT WILLIAM L [US]) [DA] 1,17-23* claim - *; | [A]WO9942476 (ADVANCED MEDICINE INC [US]) [A] 1,17-23 * claim - *; | [DA]WO9964049 (ADVANCED MEDICINE INC [US], et al) [DA] 1,17-23 * claim - *; | [A]WO0039156 (ADVANCED MEDICINE INC [US], et al) [A] 1,17-23 * claim - *; | [A] - HAMMES W.P., "Biosynthesis of peptidoglycan in Gaffkya homari. The mode of action of penicillin G and mecillinam", CHEMICAL ABSTRACTS, (19770131), vol. 86, no. 5, Database accession no. 26406, XP002245292 [A] 1,19 * abstract * | [ ] - EUR. J. BIOCHEM., (1976), vol. 70, no. 1, pages 107 - 113 |